SPONSOR
RECORDATI GROUP
Total Trials
2
Recruiting
2
Phases
Phase 2
RECORDATI GROUP is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Cushing Syndrome, Hyperammonemia, Methylmalonic Acidemia, Propionic Acidemia.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — RECORDATI GROUP
How many clinical trials has RECORDATI GROUP sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by RECORDATI GROUP, of which 2 are actively recruiting participants. These trials cover conditions including Cushing Syndrome, Hyperammonemia, Methylmalonic Acidemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does RECORDATI GROUP research focus on?
RECORDATI GROUP clinical trials span Cushing Syndrome, Hyperammonemia, Methylmalonic Acidemia, Propionic Acidemia. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a RECORDATI GROUP clinical trial?
To participate in a RECORDATI GROUP trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all RECORDATI GROUP trials with current recruitment status updated daily.
Clinical Trials by RECORDATI GROUP
NCT03708900 Phase 2
Recruiting
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Cushing Syndrome
NCT05040178
Recruiting
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
Hyperammonemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology